NO995040D0 - 5-aryl-3-(8-azabicyklo(3.2.2)okt-3-yl)-1,3,4-oksadiazol-2(3H)-on-derivater som 5-HT4 reseptorligander - Google Patents

5-aryl-3-(8-azabicyklo(3.2.2)okt-3-yl)-1,3,4-oksadiazol-2(3H)-on-derivater som 5-HT4 reseptorligander

Info

Publication number
NO995040D0
NO995040D0 NO995040A NO995040A NO995040D0 NO 995040 D0 NO995040 D0 NO 995040D0 NO 995040 A NO995040 A NO 995040A NO 995040 A NO995040 A NO 995040A NO 995040 D0 NO995040 D0 NO 995040D0
Authority
NO
Norway
Prior art keywords
azabicyclo
oxadiazole
oct
aryl
derivatives
Prior art date
Application number
NO995040A
Other languages
English (en)
Other versions
NO995040L (no
Inventor
Samir Jegham
Alistair Lochead
Frederic Galli
Alain Nedelec
Axelle Samson
Thierry Gallet
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO995040D0 publication Critical patent/NO995040D0/no
Publication of NO995040L publication Critical patent/NO995040L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO995040A 1997-04-18 1999-10-15 5-aryl-3-(8-azabicyklo(3.2.2)okt-3-yl)-1,3,4-oksadiazol-2(3H)- on-derivater som 5-HT4 reseptorligander NO995040L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9704802A FR2762316B1 (fr) 1997-04-18 1997-04-18 Derives de 5-aryl-3-(8-azabicyclo[3.2.1] octan-3-yl)-1,3,4- oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
PCT/FR1998/000754 WO1998047898A1 (fr) 1997-04-18 1998-04-15 Derives de 5-aryl-3-(8-azabicyclo(3.2.2)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one en tant que ligands des recepteurs 5-ht4

Publications (2)

Publication Number Publication Date
NO995040D0 true NO995040D0 (no) 1999-10-15
NO995040L NO995040L (no) 1999-12-16

Family

ID=9506076

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995040A NO995040L (no) 1997-04-18 1999-10-15 5-aryl-3-(8-azabicyklo(3.2.2)okt-3-yl)-1,3,4-oksadiazol-2(3H)- on-derivater som 5-HT4 reseptorligander

Country Status (32)

Country Link
US (1) US6255319B1 (no)
EP (1) EP0975631B1 (no)
JP (1) JP2001521542A (no)
KR (1) KR20010006452A (no)
CN (1) CN1260794A (no)
AR (1) AR012458A1 (no)
AT (1) ATE206424T1 (no)
AU (1) AU742666B2 (no)
BG (1) BG64053B1 (no)
BR (1) BR9808926A (no)
CA (1) CA2286106A1 (no)
CO (1) CO4750656A1 (no)
CZ (1) CZ289154B6 (no)
DE (1) DE69801905T2 (no)
DK (1) DK0975631T3 (no)
EE (1) EE03769B1 (no)
ES (1) ES2165162T3 (no)
FR (1) FR2762316B1 (no)
HU (1) HUP0002456A3 (no)
IL (1) IL132352A0 (no)
NO (1) NO995040L (no)
NZ (1) NZ500396A (no)
PL (1) PL186894B1 (no)
PT (1) PT975631E (no)
RU (1) RU2186066C2 (no)
SI (1) SI0975631T1 (no)
SK (1) SK283441B6 (no)
TR (1) TR199902600T2 (no)
TW (1) TW502005B (no)
UA (1) UA57071C2 (no)
WO (1) WO1998047898A1 (no)
ZA (1) ZA983257B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0211230D0 (en) * 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
ATE474577T1 (de) * 2003-03-26 2010-08-15 Merck Sharp & Dohme Bicyclische piperidin-derivate als melanocortin-4 rezeptor-agonisten
AU2004290520A1 (en) * 2003-11-18 2005-06-02 Boehringer Ingelheim International Gmbh Solid pharmaceutical preparation form
US7737163B2 (en) 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
EP1758891A2 (en) 2004-06-15 2007-03-07 Pfizer Japan Inc. Benzimidazolone carboxylic acid derivatives
SE532388C2 (sv) * 2008-03-14 2010-01-12 Tetra Laval Holdings & Finance Förpackningslaminat och -behållare med två separata gasbarriärskikt samt metod för deras framställning
PL2967067T3 (pl) * 2013-03-15 2018-04-30 Monsanto Technology Llc N-,C-Dipodstawione azole do kontroli szkodników nicieniowych
GB201814151D0 (en) 2018-08-31 2018-10-17 Ucl Business Plc Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3294611B2 (ja) * 1991-09-12 2002-06-24 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５−ｈｔ４レセプター・アンタゴニスト
ATE169015T1 (de) * 1992-02-04 1998-08-15 Eisai Co Ltd Aminobenzoesäure derivate
AU667874B2 (en) * 1992-02-06 1996-04-18 Smithkline Beecham Plc Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists
JP3235913B2 (ja) * 1993-07-30 2001-12-04 エーザイ株式会社 アミノ安息香酸誘導体
NZ321626A (en) * 1995-11-09 1998-10-28 Synthelabo 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one derivatives for use as 5-ht4 or h3 receptor ligands

Also Published As

Publication number Publication date
TW502005B (en) 2002-09-11
CZ364199A3 (cs) 2000-03-15
EE9900487A (et) 2000-06-15
WO1998047898A1 (fr) 1998-10-29
HUP0002456A3 (en) 2001-03-28
HUP0002456A2 (hu) 2000-12-28
BG103810A (en) 2000-06-30
NZ500396A (en) 2001-04-27
ZA983257B (en) 1998-10-19
DE69801905D1 (de) 2001-11-08
KR20010006452A (ko) 2001-01-26
AR012458A1 (es) 2000-10-18
RU2186066C2 (ru) 2002-07-27
AU7341598A (en) 1998-11-13
PL336315A1 (en) 2000-06-19
CN1260794A (zh) 2000-07-19
UA57071C2 (uk) 2003-06-16
ES2165162T3 (es) 2002-03-01
TR199902600T2 (xx) 2000-03-21
FR2762316A1 (fr) 1998-10-23
AU742666B2 (en) 2002-01-10
CO4750656A1 (es) 1999-03-31
FR2762316B1 (fr) 1999-12-17
CA2286106A1 (en) 1998-10-29
DE69801905T2 (de) 2002-07-04
PL186894B1 (pl) 2004-03-31
US6255319B1 (en) 2001-07-03
SK142699A3 (en) 2000-05-16
DK0975631T3 (da) 2002-01-28
BR9808926A (pt) 2000-08-01
EP0975631A1 (fr) 2000-02-02
JP2001521542A (ja) 2001-11-06
EP0975631B1 (fr) 2001-10-04
BG64053B1 (bg) 2003-11-28
PT975631E (pt) 2002-03-28
SI0975631T1 (en) 2002-06-30
ATE206424T1 (de) 2001-10-15
NO995040L (no) 1999-12-16
EE03769B1 (et) 2002-06-17
IL132352A0 (en) 2001-03-19
CZ289154B6 (cs) 2001-11-14
SK283441B6 (sk) 2003-07-01

Similar Documents

Publication Publication Date Title
NO982092L (no) 5-fenyl-3-(piperidin-4-yl)-1,3,4-oksadiazol-2(3H)-on-derivater, for anvendelse som 5-HT4 eller H3 reseptorligander
ZA988078B (en) Substituted oxindole derivatives.
NO913786L (no) Fremgangsmaate for fremstilling av fibrinogenreseptorantagonister.
SG71077A1 (en) 8-Substituted-1,3, 8-triaza-spiro (4.5)decan-4-on derivatives
AU5640299A (en) 4-quinolinemethanol derivatives as purine receptor antagonists.(ii)
ZA989204B (en) Halogen substituted tetracyclic tetrahydrofuran derivatives.
TR199802520A3 (tr) 1,3,8-Triaza-spiro(4,5) dekan -4-on türevleri.
NO995040D0 (no) 5-aryl-3-(8-azabicyklo(3.2.2)okt-3-yl)-1,3,4-oksadiazol-2(3H)-on-derivater som 5-HT4 reseptorligander
TR199901381A3 (tr) Diaza-spiro[3,5]nonan türevleri.
DK1070065T3 (da) Azabicykliske 5-HT1 receptorligander
NO911200D0 (no) Fremgangsmaate for fremstilling av selektive adenosin-receptor midler.
EP0681583A1 (en) TRICYCLIC HETEROCYCLIC COMPOUNDS AS 5-HT4 RECEPTOR ANTAGONISTS.
FI873940A0 (fi) Pyrido (3,2,1-ij)-1,3,4 -benzoxadiazinderivat.
FI922903A (fi) 4-acetoxipiperidin derivat, deras framstaellningsfoerfarande och anvaendning som antagonist foer muskarina m-3 receptorer.
FI891913A0 (fi) Substituerade 2-tiadiazolyllarbonyl -cyklohexan-1,3-dioner och deras iminoderivat, foerfarande foer framstaellning av dessa foereningar och deras anaevaendning som medel med herbicid och vaextreglerande verkan.
NO894707D0 (no) Fremgangsmaate for fremstilling av benzoxazinderivater.
DK1133494T3 (da) 8-Azabicyclo[3.2.1]oct-2-en-derivater
FI890499A (fi) Ti02-pigment, vilka motverkar missfaergning i naervaro av polymeradditiv.
AU1449997A (en) Diazabicyclo-octane derivatives as 5-ht receptor ligands
ZA9600758D (en) Idole derivatives as 5-ht receptor antagonist.
ZA926890B (en) 5-HT4 receptor antagonists.
FI904279A0 (fi) Pyrido-(3,2,1-ij)-1,3,4 -benzoxadiazin-6-karboxylsyraderivat.
AR245006A1 (es) Una bocha para juegos deportivos.
ZA919960B (en) Serotonin antagonists.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application